Skip to main content
Premium Trial:

Request an Annual Quote

Natera, Brazilian Hospital Ink Deal for Panorama Test

NEW YORK (GenomeWeb News) – Natera announced a deal with Hospital Israelita Albert Einstein in São Paulo to offer Natera's Panorama non-invasive prenatal test.

Financial and other terms of the deal were not disclosed.

"This test enables us to provide expecting parents with reliable information about the genetics of their baby early on in pregnancy," the hospital's Director of Maternal Fetal Medicine, Rita Sanchez, said in a statement.

Using a blood draw, Panorama examines cell-free DNA found in maternal blood and detects for trisomy 21, 18, and 13, as well as for monosomy X, triploidy, and vanishing twins.

Last week, the San Carlos, Calif.-based firm said that Panorama, along with similar tests from Illumina's Verinata Health and Ariosa Diagnostics, are being offered through the California Prenatal Screening Program. In recent months, Natera also announced distribution deals with Solstas Lab Partners and LifeLabs.